Citadel Advisors
DBVT

Citadel Advisors’s DBV Technologies DBVT Stock Holding History

Citadel Advisors’s Portfolio DBVT Stock Details DBVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-145,129
Closed -$2.78M – 13184
2025
Q4 		$2.78M Buy
145,129
+123,080
+558% +$1.92M ﹤0.01% 5311
2025
Q3 		$220K Buy
+22,049
New +$215K ﹤0.01% 11055
2024
Q4 		– Sell
-6,894
Closed -$24.1K – 14653
2024
Q3 		$24.1K Sell
6,894
-5,327
-44% -$22.5K ﹤0.01% 12627
2024
Q2 		$48.9K Sell
12,221
-2,981
-20% -$18.3K ﹤0.01% 11782
2024
Q1 		$115K Sell
15,202
-1,133
-7% -$9.63K ﹤0.01% 11165
2023
Q4 		$156K Buy
16,335
+7,786
+91% +$75.4K ﹤0.01% 10327
2023
Q3 		$116K Buy
8,549
+5,659
+196% +$88.7K ﹤0.01% 10702
2023
Q2 		$54.9K Buy
+2,890
New +$52.3K ﹤0.01% 11695
2021
Q4 		– Sell
-2,028
Closed -$68.6K – 13928
2021
Q3 		$99K Sell
2,028
-155
-7% -$8.01K ﹤0.01% 12879
2021
Q2 		$119K Buy
2,183
+243
+13% +$14.5K ﹤0.01% 12749
2021
Q1 		$103K Buy
1,940
+334
+21% +$17.7K ﹤0.01% 12448
2020
Q4 		$42K Buy
+1,606
New +$35.6K ﹤0.01% 10629
2020
Q3 		– Sell
-54,164
Closed -$1.56M – 10161
2020
Q2 		$2.38M Sell
54,164
-41,956
-44% -$2.14M ﹤0.01% 4269
2020
Q1 		$3.77M Buy
96,120
+81,161
+543% +$7.28M ﹤0.01% 3113
2019
Q4 		$1.6M Buy
14,959
+10,565
+240% +$845K ﹤0.01% 4769
2019
Q3 		$378K Sell
4,394
-5,260
-54% -$501K ﹤0.01% 7222
2019
Q2 		$794K Buy
9,654
+1,148
+13% +$103K ﹤0.01% 6079
2019
Q1 		$655K Buy
8,506
+5,305
+166% +$403K ﹤0.01% 6334
2018
Q4 		$206K Sell
3,201
-1,220
-28% -$196K ﹤0.01% 7819
2018
Q3 		$993K Sell
4,421
-43,054
-91% -$8.75M ﹤0.01% 5553
2018
Q2 		$9.16M Sell
47,475
-34,162
-42% -$7.7M ﹤0.01% 2034
2018
Q1 		$18.8M Buy
81,637
+52,749
+183% +$12.5M 0.01% 1172
2017
Q4 		$7.11M Buy
28,888
+10,522
+57% +$3.04M ﹤0.01% 2070
2017
Q3 		$7.79M Buy
+18,366
New +$7.87M 0.01% 1845
2015
Q4 		– Sell
-2,009
Closed -$715K – 8780
2015
Q3 		$715K Buy
+2,009
New +$790K ﹤0.01% 4272

Other funds holding DBVT

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Citadel Advisors's DBVT Position: Q1 2026 in Review

Citadel Advisors sold out of DBV Technologies (DBVT) in Q1 2026, closing a stake of 145,129 shares — an estimated $2.78M sold.

Citadel Advisors first reported a position in DBVT in Q3 2015 and held it in 25 quarters. The position peaked at $18.8M in Q1 2018. 71 funds tracked by Wall St. Rank hold DBVT as of Q1 2026.

  • Citadel Advisors reported no remaining DBV Technologies position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 145,129 DBV Technologies shares in Q1 2026, an estimated $2.78M.
  • Citadel Advisors first reported a position in DBV Technologies in Q3 2015 and held it in 25 quarters.
  • Citadel Advisors's DBV Technologies position peaked at $18.8M in Q1 2018.
  • 71 funds tracked by Wall St. Rank held DBV Technologies as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.